Santen Pharmaceutical Co., Ltd. (TYO:4536)

Japan · Delayed Price · Currency is JPY

2,171.50

-2.50 (-0.11%)

At close: Jul 9, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceutical Products	291.62B	300.00B	301.97B	279.04B	266.26B
Pharmaceutical Products Growth	-2.79%	-0.65%	8.22%	4.80%	6.67%
Total	291.62B	300.00B	301.97B	279.04B	266.26B
Total Growth	-2.79%	-0.65%	8.22%	4.80%	6.67%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Europe, Middle East and Africa (EMEA)	80.10B	74.32B	64.76B	52.51B	42.90B
Europe, Middle East and Africa (EMEA) Growth	7.77%	14.77%	23.31%	22.41%	13.20%
Others	1.45B	1.35B	-	-	-
Others Growth	7.56%	-	-	-	-
Japan	146.81B	165.31B	175.61B	177.37B	173.63B
Japan Growth	-11.19%	-5.86%	-1.00%	2.15%	2.66%
China	30.01B	28.93B	29.86B	21.55B	27.20B
China Growth	3.75%	-3.12%	38.58%	-20.78%	16.48%
Asia (Exclude China)	33.25B	30.10B	28.67B	24.12B	19.81B
Asia (Exclude China) Growth	10.48%	4.99%	18.86%	21.73%	15.08%
Americas	-	-	3.08B	3.49B	2.72B
Americas Growth	-	-	-11.75%	28.47%	35.01%
Total	291.62B	300.01B	301.97B	279.04B	266.26B
Total Growth	-2.79%	-0.65%	8.22%	4.80%	6.67%